1: Matveychuk D, Nunes E, Ullah N, Aldawsari FS, Velázquez-Martínez CA, Baker GB. Elevation of rat brain tyrosine levels by phenelzine is mediated by its active metabolite β-phenylethylidenehydrazine. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Aug 4;53:67-73. doi: 10.1016/j.pnpbp.2014.02.011. Epub 2014 Mar 6. PubMed PMID: 24607770.
2: Ramadan ZB, Wrang ML, Tipton KF. Species differences in the selective inhibition of monoamine oxidase (1-methyl-2-phenylethyl)hydrazine and its potentiation by cyanide. Neurochem Res. 2007 Oct;32(10):1783-90. Epub 2007 Apr 3. PubMed PMID: 17404836.
3: Sowa B, Rauw G, Davood A, Fassihi A, Knaus EE, Baker GB. Design and biological evaluation of phenyl-substituted analogs of beta-phenylethylidenehydrazine. Bioorg Med Chem. 2005 Jul 15;13(14):4389-95. PubMed PMID: 15927473.
4: Ramadan ZB, Dostert P, Tipton KF. Some peculiar aspects of monoamine oxidase inhibition. Neurobiology (Bp). 1999;7(2):159-74. PubMed PMID: 10591050.
5: Lewis AJ, Kerenyi NA, Feuer G. Neuropharmacology of pineal secretions. Drug Metabol Drug Interact. 1990;8(3-4):247-312. Review. PubMed PMID: 2099892.
6: Baker GB, Coutts RT. Metabolism of monoamine oxidase inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13(3-4):395-403. Review. PubMed PMID: 2664891.
7: Foster BC, Coutts RT, Pasutto FM, Mozayani A. Microbial metabolism of phenelzine and pheniprazine. Life Sci. 1988;42(3):285-92. PubMed PMID: 2892108.
8: Mozayani A, Coutts RT, Danielson T. Gas chromatographic analysis of monoalkylhydrazines. J Chromatogr. 1987 Dec 25;423:131-7. PubMed PMID: 3443642.
9: Fagervall I, Ross SB. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors. Biochem Pharmacol. 1986 Apr 15;35(8):1381-7. PubMed PMID: 2870717.
10: Szadowska A, Mazur M, Szmigielski A, Szmigielska H, Winer A. [Heterocyclic amine derivatives - analogs of mebanazine, pheniprazine and phenelzine. II. Studies on the effect, on the central nervous system, of derivatives of perhydroazepine, perhydro-1,4-diazepine, perhydro-1,4-oxazepine, perhydro-1,5-oxazocine and morpholine-containing arylalkyloamine groups]. Acta Pol Pharm. 1983;40(1):111-8. Polish. PubMed PMID: 6136156.
11: Dorris RL. A simple method for screening monoamine oxidase (MAO) inhibitory drugs for type preference. J Pharmacol Methods. 1982 Mar;7(2):133-7. PubMed PMID: 7098495.
12: Cristofoli WA, Baker GB, Coutts RT. Amphetamine in rat brain and urine after administration of pheniprazine. Proc West Pharmacol Soc. 1982;25:129-31. PubMed PMID: 6126879.
13: Colpaert FC, Niemegeers CJ, Janssen PA. Evidence that a preferred substrate for type B monoamine oxidase mediates stimulus properties of MAO inhibitors: a possible role for beta-phenylethylamine in the cocaine cue. Pharmacol Biochem Behav. 1980 Oct;13(4):513-7. PubMed PMID: 6107935.
14: Ross SB, Ask AL. Structural requirements for uptake into serotoninergic neurones. Acta Pharmacol Toxicol (Copenh). 1980 Apr;46(4):270-7. PubMed PMID: 7368945.
15: Kawaguchi M. [Studies on As2O3-induced rabbit hypothermia and brain monoamines (author's transl)]. Nihon Yakurigaku Zasshi. 1980 Jan;76(1):77-92. Japanese. PubMed PMID: 6155319.
16: Finazzi-Agrò A, Floris G, Fadda MB, Crifò C. Inhibition of diamine oxidase by antihistaminic agents and related drugs. Agents Actions. 1979 Aug;9(3):244-7. PubMed PMID: 115254.
17: Colasanti BK, Bárány EH. Potentiation of the mydriatic effect of norepinephrine in the rabbit after monoamine oxidase inhibition. Invest Ophthalmol Vis Sci. 1979 Feb;18(2):200-3. PubMed PMID: 33123.
18: Hollingworth RM, Leister J, Ghali G. Mode of action of formamidine pesticides: an evaluation of monoamine oxidase as the target. Chem Biol Interact. 1979 Jan;24(1):35-49. PubMed PMID: 428001.
19: Pohto P. Experimental aggression and bruxism in rats. Acta Odontol Scand. 1979;37(2):117-26. PubMed PMID: 220835.
20: Quock RM, Weick BG. p-Chloroamphetamine-induced hyperthermia pharmacologically distinct from fenfluramine-induced hyperthermia. J Pharm Pharmacol. 1979 Jan;31(1):27-32. PubMed PMID: 32362.